title: Prostate cancer screening: what's a fellow to do?
abstract: Prostate cancer is responsible for more than 27,000 deaths annually and is the most common non-skin cancer of men in North America. Over the years, a variety of screening approaches have been recommended. Despite increased sensitivity of the tests and effective public awareness campaigns, screening for this cancer remains surprisingly controversial. In this article, we review what makes a good screening test. We also review the evidence behind screening for prostate cancer and the current screening recommendations by a variety of reputable organizations.
authors.affiliation: Sanford School of Medicine, The University of South Dakota, USA.
authors.forename: Fredric H
authors.initials: FH
authors.lastname: Thanel
authors.forename: Mark K
authors.initials: MK
authors.lastname: Huntington
mesh_terms: D000368:Aged; D002986:Clinical Trials as Topic; D055088:Early Detection of Cancer / Q000592:standards*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology; D012307:Risk Factors